AstraZeneca & Valeant Facing New Competition In The Opioid-Induced Constipation Arena

AstraZeneca & Valeant have been battling it out in the opioid-induced constipation arena with movantik and relistor, respectively, since winning their FDA approvals back in September 2014. Now there’s a third competitor prepping to jump into the mix.